Structure

Physi-Chem Properties

Molecular Weight:  438.15
Volume:  418.186
LogP:  -0.262
LogD:  -0.302
LogS:  -2.304
# Rotatable Bonds:  6
TPSA:  170.05
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  3
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.322
Synthetic Accessibility Score:  4.259
Fsp3:  0.476
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.945
MDCK Permeability:  2.1981108147883788e-05
Pgp-inhibitor:  0.002
Pgp-substrate:  0.985
Human Intestinal Absorption (HIA):  0.782
20% Bioavailability (F20%):  0.054
30% Bioavailability (F30%):  0.996

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.11
Plasma Protein Binding (PPB):  87.18877410888672%
Volume Distribution (VD):  0.764
Pgp-substrate:  14.875618934631348%

ADMET: Metabolism

CYP1A2-inhibitor:  0.047
CYP1A2-substrate:  0.093
CYP2C19-inhibitor:  0.009
CYP2C19-substrate:  0.338
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.152
CYP2D6-inhibitor:  0.009
CYP2D6-substrate:  0.212
CYP3A4-inhibitor:  0.006
CYP3A4-substrate:  0.039

ADMET: Excretion

Clearance (CL):  1.785
Half-life (T1/2):  0.915

ADMET: Toxicity

hERG Blockers:  0.125
Human Hepatotoxicity (H-HT):  0.067
Drug-inuced Liver Injury (DILI):  0.509
AMES Toxicity:  0.401
Rat Oral Acute Toxicity:  0.024
Maximum Recommended Daily Dose:  0.01
Skin Sensitization:  0.408
Carcinogencity:  0.04
Eye Corrosion:  0.003
Eye Irritation:  0.021
Respiratory Toxicity:  0.031

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC108706

Natural Product ID:  NPC108706
Common Name*:   2-Methyl-5-Hydroxy-6-(2-Butenyl-3-Hydroxymethyl)-7-(Beta-D-Glucopyranosyloxy)-4H-1-Benzopyran-4-One
IUPAC Name:   5-hydroxy-6-[(Z)-4-hydroxy-3-methylbut-2-enyl]-2-methyl-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one
Synonyms:  
Standard InCHIKey:  VAWXDOOFPWDVPC-XQGMFAHKSA-N
Standard InCHI:  InChI=1S/C21H26O10/c1-9(7-22)3-4-11-13(6-14-16(17(11)25)12(24)5-10(2)29-14)30-21-20(28)19(27)18(26)15(8-23)31-21/h3,5-6,15,18-23,25-28H,4,7-8H2,1-2H3/b9-3-/t15-,18-,19+,20-,21-/m1/s1
SMILES:  OC/C(=CCc1c(O[C@@H]2O[C@H](CO)[C@H]([C@@H]([C@H]2O)O)O)cc2c(c1O)c(=O)cc(o2)C)/C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2087919
PubChem CID:   70686987
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0000011] Carbohydrates and carbohydrate conjugates
          • [CHEMONTID:0002105] Glycosyl compounds
            • [CHEMONTID:0004165] Phenolic glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15544 Cnidium monnieri Species Apiaceae Eukaryota n.a. fruit n.a. PMID[10785419]
NPO15544 Cnidium monnieri Species Apiaceae Eukaryota n.a. n.a. n.a. PMID[21625478]
NPO15544 Cnidium monnieri Species Apiaceae Eukaryota fruits n.a. n.a. PMID[22932311]
NPO15544 Cnidium monnieri Species Apiaceae Eukaryota n.a. fruit n.a. PMID[23721280]
NPO15544 Cnidium monnieri Species Apiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO15544 Cnidium monnieri Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO15544 Cnidium monnieri Species Apiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO15544 Cnidium monnieri Species Apiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT520 Cell Line 3T3-L1 Mus musculus Inhibition = 87.0 % PMID[555669]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC108706 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC211158
1.0 High Similarity NPC87304
1.0 High Similarity NPC268950
1.0 High Similarity NPC78021
0.9932 High Similarity NPC470605
0.9932 High Similarity NPC470603
0.9932 High Similarity NPC470604
0.9799 High Similarity NPC470606
0.9795 High Similarity NPC38775
0.9795 High Similarity NPC191154
0.9733 High Similarity NPC470607
0.9728 High Similarity NPC134819
0.9667 High Similarity NPC23817
0.966 High Similarity NPC214454
0.966 High Similarity NPC106025
0.966 High Similarity NPC477240
0.9658 High Similarity NPC199335
0.96 High Similarity NPC17521
0.9597 High Similarity NPC106625
0.9595 High Similarity NPC190217
0.9589 High Similarity NPC23084
0.9542 High Similarity NPC44947
0.9542 High Similarity NPC131745
0.9533 High Similarity NPC95090
0.9533 High Similarity NPC27408
0.9533 High Similarity NPC99233
0.953 High Similarity NPC259182
0.953 High Similarity NPC121001
0.9524 High Similarity NPC10097
0.9481 High Similarity NPC124155
0.9481 High Similarity NPC183672
0.9481 High Similarity NPC278419
0.9481 High Similarity NPC179198
0.9481 High Similarity NPC257566
0.9481 High Similarity NPC66087
0.9477 High Similarity NPC47923
0.9474 High Similarity NPC73511
0.947 High Similarity NPC127406
0.947 High Similarity NPC206378
0.9467 High Similarity NPC210003
0.9467 High Similarity NPC29763
0.9467 High Similarity NPC83283
0.9467 High Similarity NPC39360
0.9467 High Similarity NPC143851
0.9459 High Similarity NPC139966
0.9459 High Similarity NPC307052
0.9416 High Similarity NPC190450
0.9416 High Similarity NPC259834
0.9412 High Similarity NPC472320
0.9408 High Similarity NPC161749
0.9408 High Similarity NPC197896
0.9408 High Similarity NPC44931
0.9408 High Similarity NPC313163
0.9408 High Similarity NPC108831
0.9408 High Similarity NPC129827
0.9408 High Similarity NPC258035
0.9408 High Similarity NPC156457
0.9408 High Similarity NPC60966
0.9408 High Similarity NPC6985
0.9408 High Similarity NPC43638
0.9408 High Similarity NPC182634
0.9408 High Similarity NPC65003
0.9408 High Similarity NPC473512
0.9404 High Similarity NPC26195
0.9404 High Similarity NPC39351
0.9404 High Similarity NPC72649
0.9404 High Similarity NPC97052
0.9404 High Similarity NPC169248
0.94 High Similarity NPC259767
0.94 High Similarity NPC88484
0.9396 High Similarity NPC213723
0.9351 High Similarity NPC303913
0.9346 High Similarity NPC138811
0.9346 High Similarity NPC41121
0.9346 High Similarity NPC320283
0.9346 High Similarity NPC22062
0.9346 High Similarity NPC473634
0.9346 High Similarity NPC111929
0.9346 High Similarity NPC472459
0.9342 High Similarity NPC170475
0.9342 High Similarity NPC45165
0.9342 High Similarity NPC203500
0.9342 High Similarity NPC307938
0.9342 High Similarity NPC261866
0.9342 High Similarity NPC323593
0.9333 High Similarity NPC250488
0.9324 High Similarity NPC85773
0.9324 High Similarity NPC218685
0.9286 High Similarity NPC97285
0.9286 High Similarity NPC271270
0.9286 High Similarity NPC142860
0.9286 High Similarity NPC187379
0.9286 High Similarity NPC153342
0.9286 High Similarity NPC246469
0.9286 High Similarity NPC473623
0.9281 High Similarity NPC77672
0.9281 High Similarity NPC133671
0.9281 High Similarity NPC54802
0.9281 High Similarity NPC197304
0.9281 High Similarity NPC135391
0.9281 High Similarity NPC122809
0.9281 High Similarity NPC78263
0.9272 High Similarity NPC10807
0.9272 High Similarity NPC150123
0.9272 High Similarity NPC244583
0.9272 High Similarity NPC256141
0.9272 High Similarity NPC161881
0.9272 High Similarity NPC56232
0.9257 High Similarity NPC474302
0.9241 High Similarity NPC259905
0.9241 High Similarity NPC5319
0.9236 High Similarity NPC178851
0.9226 High Similarity NPC259957
0.9226 High Similarity NPC476215
0.9226 High Similarity NPC181465
0.9226 High Similarity NPC276377
0.9226 High Similarity NPC173582
0.9226 High Similarity NPC253788
0.9226 High Similarity NPC224530
0.9226 High Similarity NPC159579
0.9226 High Similarity NPC249281
0.9226 High Similarity NPC48093
0.9226 High Similarity NPC116458
0.9226 High Similarity NPC246943
0.9226 High Similarity NPC139320
0.9226 High Similarity NPC163242
0.9226 High Similarity NPC265885
0.9226 High Similarity NPC85707
0.9226 High Similarity NPC129217
0.9226 High Similarity NPC215710
0.9226 High Similarity NPC101636
0.9226 High Similarity NPC473438
0.9226 High Similarity NPC216496
0.9221 High Similarity NPC308265
0.9221 High Similarity NPC43761
0.9216 High Similarity NPC295613
0.9216 High Similarity NPC473657
0.9216 High Similarity NPC149368
0.9216 High Similarity NPC265480
0.9205 High Similarity NPC477897
0.9205 High Similarity NPC23253
0.9205 High Similarity NPC328740
0.9205 High Similarity NPC289774
0.9205 High Similarity NPC209846
0.9195 High Similarity NPC470670
0.9195 High Similarity NPC91902
0.9195 High Similarity NPC473133
0.9195 High Similarity NPC47388
0.9182 High Similarity NPC76047
0.9182 High Similarity NPC150767
0.9182 High Similarity NPC78734
0.9177 High Similarity NPC477502
0.9172 High Similarity NPC294722
0.9167 High Similarity NPC298171
0.9167 High Similarity NPC300537
0.9167 High Similarity NPC475382
0.9167 High Similarity NPC150164
0.9167 High Similarity NPC473043
0.9167 High Similarity NPC127782
0.9167 High Similarity NPC93215
0.9167 High Similarity NPC27942
0.9167 High Similarity NPC240306
0.9161 High Similarity NPC304741
0.9161 High Similarity NPC200708
0.9161 High Similarity NPC136761
0.9161 High Similarity NPC470405
0.9161 High Similarity NPC271479
0.9161 High Similarity NPC471079
0.9156 High Similarity NPC288084
0.915 High Similarity NPC304745
0.915 High Similarity NPC87404
0.915 High Similarity NPC111341
0.915 High Similarity NPC92395
0.9139 High Similarity NPC180351
0.9125 High Similarity NPC256760
0.911 High Similarity NPC139554
0.911 High Similarity NPC471697
0.9108 High Similarity NPC309025
0.9108 High Similarity NPC121703
0.9108 High Similarity NPC222936
0.9108 High Similarity NPC473644
0.9108 High Similarity NPC243930
0.9108 High Similarity NPC19709
0.9108 High Similarity NPC94777
0.9108 High Similarity NPC311850
0.9108 High Similarity NPC88023
0.9108 High Similarity NPC284960
0.9103 High Similarity NPC195685
0.9103 High Similarity NPC270675
0.9103 High Similarity NPC210961
0.9103 High Similarity NPC135846
0.9103 High Similarity NPC64305
0.9103 High Similarity NPC472994
0.9103 High Similarity NPC470125
0.9103 High Similarity NPC477628
0.9103 High Similarity NPC477629
0.9103 High Similarity NPC282169
0.9103 High Similarity NPC170052
0.9103 High Similarity NPC297987
0.9097 High Similarity NPC104677

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC108706 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9408 High Similarity NPD4381 Clinical (unspecified phase)
0.9241 High Similarity NPD7804 Clinical (unspecified phase)
0.9013 High Similarity NPD4380 Phase 2
0.8882 High Similarity NPD7054 Approved
0.8827 High Similarity NPD7472 Approved
0.8827 High Similarity NPD7074 Phase 3
0.882 High Similarity NPD3818 Discontinued
0.879 High Similarity NPD7075 Discontinued
0.8774 High Similarity NPD6801 Discontinued
0.8773 High Similarity NPD6797 Phase 2
0.872 High Similarity NPD7251 Discontinued
0.872 High Similarity NPD6559 Discontinued
0.8718 High Similarity NPD2393 Clinical (unspecified phase)
0.8684 High Similarity NPD4378 Clinical (unspecified phase)
0.8667 High Similarity NPD7808 Phase 3
0.8599 High Similarity NPD7096 Clinical (unspecified phase)
0.8591 High Similarity NPD1550 Clinical (unspecified phase)
0.8591 High Similarity NPD1552 Clinical (unspecified phase)
0.8554 High Similarity NPD4338 Clinical (unspecified phase)
0.8535 High Similarity NPD1934 Approved
0.8533 High Similarity NPD1549 Phase 2
0.8471 Intermediate Similarity NPD7411 Suspended
0.8442 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8428 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD6166 Phase 2
0.8354 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8278 Intermediate Similarity NPD2796 Approved
0.8258 Intermediate Similarity NPD6799 Approved
0.825 Intermediate Similarity NPD2801 Approved
0.825 Intermediate Similarity NPD7819 Suspended
0.8217 Intermediate Similarity NPD5403 Approved
0.8212 Intermediate Similarity NPD1510 Phase 2
0.8199 Intermediate Similarity NPD3817 Phase 2
0.8171 Intermediate Similarity NPD6959 Discontinued
0.8148 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8141 Intermediate Similarity NPD1511 Approved
0.8089 Intermediate Similarity NPD5401 Approved
0.8067 Intermediate Similarity NPD1240 Approved
0.8065 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.8063 Intermediate Similarity NPD6599 Discontinued
0.8038 Intermediate Similarity NPD1512 Approved
0.8024 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8 Intermediate Similarity NPD2800 Approved
0.7978 Intermediate Similarity NPD7584 Approved
0.7975 Intermediate Similarity NPD5402 Approved
0.7961 Intermediate Similarity NPD1607 Approved
0.7961 Intermediate Similarity NPD6651 Approved
0.7955 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7935 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD3882 Suspended
0.7892 Intermediate Similarity NPD5494 Approved
0.7885 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7862 Intermediate Similarity NPD2532 Approved
0.7862 Intermediate Similarity NPD2534 Approved
0.7862 Intermediate Similarity NPD2533 Approved
0.7861 Intermediate Similarity NPD8312 Approved
0.7861 Intermediate Similarity NPD8313 Approved
0.7826 Intermediate Similarity NPD1653 Approved
0.7818 Intermediate Similarity NPD7768 Phase 2
0.7805 Intermediate Similarity NPD8455 Phase 2
0.7798 Intermediate Similarity NPD6232 Discontinued
0.7791 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7778 Intermediate Similarity NPD5844 Phase 1
0.7771 Intermediate Similarity NPD1243 Approved
0.7765 Intermediate Similarity NPD7473 Discontinued
0.7764 Intermediate Similarity NPD920 Approved
0.7722 Intermediate Similarity NPD3750 Approved
0.7722 Intermediate Similarity NPD4628 Phase 3
0.7697 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD1091 Approved
0.768 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7662 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7662 Intermediate Similarity NPD5124 Phase 1
0.765 Intermediate Similarity NPD6776 Approved
0.765 Intermediate Similarity NPD6782 Approved
0.765 Intermediate Similarity NPD6781 Approved
0.765 Intermediate Similarity NPD6778 Approved
0.765 Intermediate Similarity NPD6779 Approved
0.765 Intermediate Similarity NPD6780 Approved
0.765 Intermediate Similarity NPD6777 Approved
0.764 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7625 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7606 Intermediate Similarity NPD8151 Discontinued
0.76 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD5953 Discontinued
0.758 Intermediate Similarity NPD2935 Discontinued
0.758 Intermediate Similarity NPD1551 Phase 2
0.7572 Intermediate Similarity NPD7286 Phase 2
0.756 Intermediate Similarity NPD3749 Approved
0.7553 Intermediate Similarity NPD7585 Approved
0.7547 Intermediate Similarity NPD1652 Phase 2
0.7546 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD37 Approved
0.7529 Intermediate Similarity NPD7199 Phase 2
0.7527 Intermediate Similarity NPD7435 Discontinued
0.7516 Intermediate Similarity NPD7033 Discontinued
0.7515 Intermediate Similarity NPD6234 Discontinued
0.7515 Intermediate Similarity NPD919 Approved
0.7514 Intermediate Similarity NPD7228 Approved
0.7514 Intermediate Similarity NPD3751 Discontinued
0.75 Intermediate Similarity NPD4966 Approved
0.75 Intermediate Similarity NPD7583 Approved
0.75 Intermediate Similarity NPD4967 Phase 2
0.75 Intermediate Similarity NPD4965 Approved
0.7485 Intermediate Similarity NPD1465 Phase 2
0.7485 Intermediate Similarity NPD3787 Discontinued
0.7473 Intermediate Similarity NPD4363 Phase 3
0.7473 Intermediate Similarity NPD4360 Phase 2
0.7468 Intermediate Similarity NPD2313 Discontinued
0.7455 Intermediate Similarity NPD7458 Discontinued
0.7436 Intermediate Similarity NPD1933 Approved
0.7435 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7435 Intermediate Similarity NPD7783 Phase 2
0.7433 Intermediate Similarity NPD7698 Approved
0.7433 Intermediate Similarity NPD7697 Approved
0.7433 Intermediate Similarity NPD7696 Phase 3
0.7427 Intermediate Similarity NPD1247 Approved
0.7405 Intermediate Similarity NPD2799 Discontinued
0.7405 Intermediate Similarity NPD3748 Approved
0.7394 Intermediate Similarity NPD7871 Phase 2
0.7394 Intermediate Similarity NPD7870 Phase 2
0.7391 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD5711 Approved
0.7384 Intermediate Similarity NPD5710 Approved
0.738 Intermediate Similarity NPD6823 Phase 2
0.7377 Intermediate Similarity NPD6534 Approved
0.7377 Intermediate Similarity NPD6535 Approved
0.7375 Intermediate Similarity NPD2424 Discontinued
0.7372 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7372 Intermediate Similarity NPD1613 Approved
0.7368 Intermediate Similarity NPD7701 Phase 2
0.7365 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD6100 Approved
0.7358 Intermediate Similarity NPD6099 Approved
0.7355 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD3226 Approved
0.7348 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD7685 Pre-registration
0.7341 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD6832 Phase 2
0.7333 Intermediate Similarity NPD422 Phase 1
0.7333 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD230 Phase 1
0.732 Intermediate Similarity NPD2798 Approved
0.7292 Intermediate Similarity NPD7874 Approved
0.7292 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD9717 Approved
0.7258 Intermediate Similarity NPD7699 Phase 2
0.7258 Intermediate Similarity NPD7700 Phase 2
0.7256 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD7390 Discontinued
0.7255 Intermediate Similarity NPD1203 Approved
0.7254 Intermediate Similarity NPD7801 Approved
0.7244 Intermediate Similarity NPD6798 Discontinued
0.7244 Intermediate Similarity NPD3268 Approved
0.7226 Intermediate Similarity NPD4908 Phase 1
0.7222 Intermediate Similarity NPD2654 Approved
0.7205 Intermediate Similarity NPD2344 Approved
0.7205 Intermediate Similarity NPD2346 Discontinued
0.7188 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7181 Intermediate Similarity NPD1548 Phase 1
0.7161 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD943 Approved
0.7151 Intermediate Similarity NPD4361 Phase 2
0.7151 Intermediate Similarity NPD7240 Approved
0.7151 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8434 Phase 2
0.7143 Intermediate Similarity NPD2797 Approved
0.7143 Intermediate Similarity NPD3926 Phase 2
0.7135 Intermediate Similarity NPD6213 Phase 3
0.7135 Intermediate Similarity NPD6212 Phase 3
0.7135 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD7097 Phase 1
0.712 Intermediate Similarity NPD8319 Approved
0.712 Intermediate Similarity NPD8320 Phase 1
0.7117 Intermediate Similarity NPD6674 Discontinued
0.7115 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7107 Intermediate Similarity NPD447 Suspended
0.7105 Intermediate Similarity NPD1610 Phase 2
0.7102 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD7266 Discontinued
0.709 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD6233 Phase 2
0.707 Intermediate Similarity NPD3027 Phase 3
0.7067 Intermediate Similarity NPD9545 Approved
0.7056 Intermediate Similarity NPD7930 Approved
0.7049 Intermediate Similarity NPD8150 Discontinued
0.7041 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD1729 Discontinued
0.703 Intermediate Similarity NPD2309 Approved
0.7025 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD1296 Phase 2
0.7006 Intermediate Similarity NPD4661 Approved
0.7006 Intermediate Similarity NPD4662 Approved
0.7006 Intermediate Similarity NPD2403 Approved
0.7 Intermediate Similarity NPD6355 Discontinued
0.7 Intermediate Similarity NPD3823 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data